Therapeutic potential of β-arrestin- and G protein-biased agonists

This publication has 249 references indexed in Scilit:

• Regulation of lipopolysaccharide‐induced inflammatory response and endotoxemia by β‐arrestins
  Journal of Cellular Physiology, 2010
• Troglitazone stimulates β-arrestin-dependent cardiomyocyte contractility via the angiotensin II type 1A receptor
  Biochemical and Biophysical Research Communications, 2010
• β-Arrestins modulate Adenovirus-vector-induced innate immune responses: Differential regulation by β-arrestin-1 and β-arrestin-2
  Virus Research, 2009
• β-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFκB gene expression network in osteoblasts
  Bone, 2009
• Physiological and pharmacological implications of beta-arrestin regulation
  Pharmacology & Therapeutics, 2008
• Translocation of arrestin induced by human A3 adenosine receptor ligands in an engineered cell line: Comparison with G protein-dependent pathways
  Pharmacological Research, 2008
• Recruitment of β-arrestin2 to the dopamine D2 receptor: Insights into anti-psychotic and anti-parkinsonian drug receptor signaling
  Neuropharmacology, 2008
• Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia
  Neurobiology of Aging, 2008
• Diversity of actions of GnRHs mediated by ligand-induced selective signaling
  Frontiers in Neuroendocrinology, 2008
• Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors
  Neuropharmacology, 2007